Clinerion is the worldwide leader in medical data informatics, radically improving efficiency in patient search and identification, increasing effectiveness in clinical research and accelerating the process of drug development to ensure an earlier availability of medicines.

How has Clinerion technology solution benefited hospitals? What have their experiences been? IT and healthcare specialists Creative Intellect Consulting's case study goes into the user experience.

Abstract: As the development of drugs is a highly expensive and a long-drawn out process, it makes good sense to use technology where possible, to make the procedure more efficient and timely, without comprising security. Replacing manual screening with an electronic search routine is a serious improvement, as has been demonstrated by the experiences of users of Clinerion’s PRS.

How do Clinerion's patient data solutions support hospitals and their patients? IT and healthcare specialists Creative Intellect Consulting's white paper goes into detail.

Abstract: As a result of the efficiency increase occasioned by PRS, and of the higher exposure to Clinerion’s international clients, hospitals in the PRS network have a higher likelihood of participating in leading-edge sponsored trials, which can improve their academic reputation and increase institutional revenues.

Abstract: A brief overview of historical development of the clinical industry and its effect on life expectancy of patients is given. The general trends of study sample site increase, reduced patient participations and challenges associated with patient recruitment and retention are reviewed. A case is made for replacing manual database scanning with IT infrastructure, resulting in quicker identification of eligible patients. Patient Recruitment System (PRS) developed by Clinerion is presented and its three main features (protocol authoring, feasibility and real-time recruitment) are reviewed. Implications of global implementation of PRS on site selection process and clinical trial management in general are discussed.

Towards the end of 2014, one of the largest biotech companies in the world started using Clinerion's technology solution for an ongoing dyslipidemia clinical trial.

This was an exciting time for the study team as the principal investigator (PI) was hoping to exceed her committed number of enrolled patients and become one of the best performing sites with the help of this new innovative technology.

Three months into the trial the study team had only enrolled about a third of the required number of patients. After activating Clinerion, the PI was able to reach the remaining 64% of her commitment within only a month and a half! This result was achieved by only validating 15% of the patient candidates identified by Clinerion. The recruiting process had an early closure due to this high performance of the clinical trial site.

One of the study team members reported: “Normally it takes hours to screen the archives for one eligible patient. However, with such an online tool we spent much less time finding patients and consequently had more time for other tasks. This had a great positive impact on our study quality!”